地塞米松降低慢性硬膜下血肿患者再手术率的作用分析

Analysis of reoperation rate in patients with chronic subdural hematoma treated by dexamethasone

目的观察地塞米松降低慢性硬膜下血肿(CSDH)患者再手术率的作用。方法选取崇左市人民医院收治的慢性硬膜下血肿患者60例,随机分为对照组和研究组各30例,对照组单纯采取手术治疗,研究组在手术治疗的基础上联合地塞米松药物治疗,比较2组术后1、3、6个月的颅内残余血肿量及再手术率。结果 2组术后1、3、6个月颅内残余血肿量的比较差异有统计学意义(P<0.05);研究组和对照组再手术率分别为6.7%和26.7%,差异有统计学意义(P<0.05)。结论地塞米松能够降低CSDH再手术率,减少颅内残余血肿量。

Objective To observe the clinical reoperation rate in patients with chronic subdural hematoma （CSDH） treated by dexamethasone and operation. Methods A total of 60 cases with CSDH in our hospital were divided into control group and study group,30 cases in each group. The former group only received operation and the latter received dexamethasone on the basis of operation. Then the remnant hematoma volume and reoperation rate at the 1st, 3rd and 6th months were compared in the two groups. Results Significantly statistical difference was found as for remnant hematoma volume at the 1st, 3rd and 6th months （P〈0. 05）. The reoperation rate was 6.7 % in the study group and was 26.7% in control group, and the difference was significant （P〈0. 05）. Conclusion Dexamethasone combined with operation can effectively reduce reoperation rate and remnant hematoma volume in CSDH patients.